|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2005-6-29
|
|
pubmed:abstractText |
Approved dosage regimens for prescription drug products are developed with a view to obtaining a favourable therapeutic index in the overall exposed population. The purpose of this study was to examine differences between the approved dosage regimen and the clinically prescribed doses of allopurinol in major hospitals in Japan.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0269-4727
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
407-12
|
|
pubmed:dateRevised |
2008-5-28
|
|
pubmed:meshHeading |
pubmed-meshheading:15985055-Administration, Oral,
pubmed-meshheading:15985055-Aged,
pubmed-meshheading:15985055-Allopurinol,
pubmed-meshheading:15985055-Antimetabolites,
pubmed-meshheading:15985055-Dose-Response Relationship, Drug,
pubmed-meshheading:15985055-Female,
pubmed-meshheading:15985055-Humans,
pubmed-meshheading:15985055-Japan,
pubmed-meshheading:15985055-Male,
pubmed-meshheading:15985055-Middle Aged,
pubmed-meshheading:15985055-Physician's Practice Patterns
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Appropriate dosing regimen of allopurinol in Japanese patients.
|
|
pubmed:affiliation |
Department of Pharmacy, National Cardiovascular Center, Suita-city, Osaka, Japan. takada@hsp.ncvc.go.jp
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
